Cite Filings / IMDX / 0000919574-26-002415

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Insight Molecular Diagnostics Inc. Filed 2026-04-27 Acc 0000919574-26-002415

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-04-30 ARS Annual Report to Security Holders
2026-04-30 DEFA14A Proxy Materials
2026-04-30 DEF 14A Proxy Statement
2026-04-30 8-K Other events
2026-04-27 SCHEDULE 13D/A Beneficial Ownership Report
2026-04-27 4 10% owner bought 570,184 shares at an average $3.56 ($2,032,251)
2026-02-12 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…